“Tranq Burn”: Exploring the Etiology of Tranq-Related Soft Tissue Injuries Dan Ciccarone, MD, MPH; University of California, San Francisco
“Expedited Referrals” from SSP to OTP: Innovative Approaches to Reducing Barriers to Methadone Treatment for Patients Who Use Opioids and Experience Homelessness Natalie Stahl, MD, MPH1, Avik Chatterjee, MD, MPH2, Rebecca Weiner, MD1, Amy Bositis, MSN1; (1)Greater Lawrence Family Health Center, (2)Boston University Chobanian & Avedisian School of Medicine
“Just be Relentless,” Lessons Learned from in-Hospital Addiction Consult Service Implementation Beth E Williams, AGNP, MPH; Oregon Health & Science University
“The Go-To Response Is Let’s Get Them Back in Here”: Factors Influencing Adoption of Low-Barrier Treatment Practices in Outpatient Buprenorphine Maggie Lowenstein, MD, MPhil, MSHP; Penn Center for Addiction Medicine and Policy; University of Pennsylvania Perelman School of Medicine
“They Treat Me Differently Now”: Two Disparate Responses to in-Hospital Substance Use Taylor S Baisey, MPH1, Johanna Sluser, FNP-C, MSN1; (1)University of California, San Francisco
”Un Attracteur De Soins”: Bringing People into Care. Qualitative Study of Interprofessional French Healthcare Clinicians’ Attitudes Towards Opioid Agonist Therapy Honora L. Englander, MD; Service Universitaire d’Addictologie de Lyon, CH Le Vinatier, Hospices Civils de Lyon, Oregon Health & Science University
“You Need to Prove That What You Say Is True”: Patient Experiences with Urine Drug Testing in Buprenorphine Treatment Andrea U Jakubowski, MD, MS1, Isabel H Lamont, BCPS1, Mariya Masyukova, MD, MS2; (1)Montefiore Medical Center/Albert Einstein College of Medicine, (2)Project Renewal, Inc.
“You Want to Know the Person That’s Lying There”: Patient Experiences of Hospital-Based Care after a Stimulant-Related Overdose Isabel H Lamont, BCPS; Montefiore Medical Center/Albert Einstein College of Medicine
A Qualitative Assessment of Healthcare Experiences of Patients Engaged By the Reach Medical Outreach Model of Care to People Who Use Drugs in Ithaca, New York Simon Gagliardi, BA; Weill Cornell Medical College
A Qualitative Assessment of the Care Transition Experience of Patients with Substance Use Disorders after Hospital Discharge Michael Incze, MD, MSEd; Annika Hansen, MA; Shanaya Fox, BS; Carolyn Bell, MD; Danielle Babbel, MD – University of Utah
A Qualitative Exploration of the Substance Use Impacts of a Large-Scale Hoteling Intervention for People Experiencing Homelessness in NYC during the COVID-19 Pandemic Hannah Passmore, MPH; New York University Grossman School of Medicine
A Qualitative Investigation of Methadone Treatment Experiences, Facilitators, and Barriers Among People Experiencing Homelessness with Opioid Use Disorder Marina Gaeta Gazzola, MD; The APT Foundation Inc., NYU Grossman School of Medicine and Bellevue Hospital Center
Accessibility to Opioid Treatment Programs (OTPs) Via Personal Vehicle Versus Mass Transit across Census Block Groups in Connecticut Benjamin A. Howell, MD, MHS, MPH; Yale University School of Medicine
Adaptation, Implementation and Evaluation of Telementoring Echo Series to Address E-Cigarette Use Among Middle and High School Students in Kansas Babalola Faseru, MD, MPH; University of Kansas Medical Center
Adaptations Made By Post-Overdose Outreach Programs in Massachusetts Since the Onset of COVID-19 Allyson G. Cogan, MPH; Boston Medical Center
An Interprofessional Case-Based Discussion on Opioid Use Disorder: Influencing Knowledge, Confidence and Stigma Among Future Prescribers Katherine Grandinetti, MPH; University of Michigan Medical School
Association of Surgery with Discontinuation of Buprenorphine for the Treatment of Opioid Use Disorder Kyle R Buchwalder, MD; University of Michigan – School of Public Health
Associations between HIV Primary Care Provider Characteristics and Harm Reduction Acceptability: A Mixed-Methods Study Mary Hawk, LSW, DrPH; University of Pittsburgh
Attitudes Toward Medications for Opioid Use Disorder Among Residents in Low-Threshold Harm Reduction Housing Sites in Boston Avik Chatterjee, MD, MPH; Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine
Attributes of Higher- and Lower-Performing Hospitals in the Consult for Addiction Treatment and Care in Hospitals (CATCH) Program Implementation: A Multiple-Case Study Carla King, MPH; New York University Grossman School of Medicine
Barriers and Facilitators of Medication for Opioid Use Disorder (MOUD) in Skilled Nursing Facilities (SNFs) Justina L Groeger, MD, MPH1, Kristine E. Torres-Lockhart, MD1; (1)Montefiore Medical Center/Albert Einstein College of Medicine
Beyond the X-Waiver: Perspectives on Buprenorphine Access & Barriers in the Outpatient Setting Maggie Lowenstein, MD, MPhil, MSHP; Penn Center for Addiction Medicine and Policy; University of Pennsylvania Perelman School of Medicine
Buprenorphine in Jails: An Innovative Mixed-Methods Pilot Project in Rural Appalachia Robert Lyle Cooper, PhD1, Loren Deborah Ginn, MSSW1; (1)Meharry Medical College
Buprenorphine Induction As a Support for Families with Child Protective Services (CPS) Involvement Matthew Holm, MD1, Zina Huxley-Reicher, MD2; (1)Montefiore Medical Center/Albert Einstein College of Medicine, (2)NYC Health + Hospitals/Woodhull Medical and Mental Health Center/NYU
Buy and Bill Vs Patient Supplied XR Bup: A Nursing Administration Perspective Charina Hanley, BSN, RN, CARN; Boston Health Care for the Homeless Program
Caring for Individuals with Substance Use Disorder during Childbirth: Experiences of Rural Healthcare Providers Assumpta S Nantume, MSc; University of Utah
Centering a Harm Reduction Framework for Substance Use Disorder Counseling in Medical Student Education: A Pilot Curriculum Ana Malfa, BA1, Katie Zechnich, BA1; (1)The Warren Alpert Medical School of Brown University
Changes in Buprenorphine Prescribing Among Pregnant and Postpartum Individuals Following Postpartum Medicaid Expansion in South Carolina Kristin C Prewitt, MD, MPH1, Megan Fuerst, MD, MPH1; (1)Oregon Health & Science University
Co-Developing and Implementing a Promotor Curriculum: Program for Education in Drugs and Alcohol for Latine (PEDAL) Marlene Martin, MD1, Triveni DeFries, MD, MPH1; (1)University of California, San Francisco
Code Bupe: Implementing Post-Overdose EMS Buprenorphine Programs across Missouri Rachel Winograd, PhD; University of Missouri, St. Louis
Collocated Care: A Peripartum Clinic at the Heart of the Opioid Epidemic Nia M Bhadra-Heintz, MD, MSc1, Navid Roder, MD1; (1)Hospital of the University of Pennsylvania
Combined Contingency Management for Stimulant Use Disorder and ART Adherence: An Implementation-Effectiveness Pilot in HIV Primary Care Gabriela Milagro Steiner, Medical Student, MSc; University of California, San Francisco
Comparing Long-Acting Injectable Versus Oral HIV Antiretroviral Therapy for People Who Use Drugs Kathleen O’Connor, Medical Student1, Nicky J Mehtani, MD, MPH2; (1)SFDPH- Whole Person Integrated Care, (2)University of California, San Francisco
Creating Clinical Partnerships with Law Enforcement to Support for People Who Use Drugs Using a Harm Reduction Lens Gilly Gehri, BA1, Nicole O’Donnell, CRS1; (1)University of Pennsylvania
Curriculum for Pediatric Residents on SBIRT in Primary Care Margaret Shang, MD; University of Pittsburgh Medical Center
Demand and Supply of Telemedicine Services for Racial and Ethnic Minority High Schoolers Affected By Violence and Substance Use During the Pandemic Chuka Nestor Emezue, MPA, MPH, PhD; Rush University Medical Center
Development and Implementation of a 24/7 State-Wide Telehealth Hotline for Initiation of Buprenorphine for People with OUD in Washington State Olivia P Hood, MPH; University of Washington
Development and Training for Peer-Delivered Contingency Management for Stimulant Use Harm Reduction across Oregon Linda Peng, MD1, Erin Stack, MSc2; (1)Oregon Health & Science University, (2)Comagine Health
Disparities in Patterns of Prescription Stimulant Use for ADHD in US Children Jennie E Ryan, CRNP, PhD; Thomas Jefferson University
Early Results of a Rapid Methadone Titration Initiation Protocol for Hospitalized Patients with Opioid Use Disorder Marlene Martin, MD1, Leslie W. Suen, MAS, MD1; (1)University of California, San Francisco
Effectiveness of the NO Stigma Simulation Suite in Reducing Stigma and Improving Attitudes and Empathy in Opioid Use Disorder Care: A Pilot Study Mary K. McCurry, ACNP, ANP-BC, PhD, RN-BC; University of Massachusetts Dartmouth
Embedding and Sustaining Peers in Emergency Departments: Exploring Program Implementation and Outcomes Jasmine S Barnes, MPH; University of Pennsylvania
Empowering Harm Reduction: A Cost-Efficient Training Program for Contingency Management in Syringe Services Programs Gaurika Mester, Medical Student1, Katrina Ciraldo, MD1; (1)University of Miami, Miller School of Medicine
Enhancing Family Engagement in Substance Use Disorder Treatment: A Training Intervention for Addiction Professionals Alicia S Ventura, MPH; Boston Medical Center and Boston University Chobanian & Avedisian School of Medicine, Boston Medical Center
Evaluating an Atlantic Canadian Injectable Opioid Agonist Treatment Program from the Perspective of Program Users Adrienne N Thornton, BS; University of New Brunswick
Evaluating the Quality of Medication Assisted Treatment for Opioid Use Disorder in New Jersey County Jails: A Comprehensive Needs Assessment Approach Pamela Valera, PhD1, Clement Chen, PharmD2; (1)Rutgers University School of Public Health, (2)Rutgers University New Jersey of Medical School, The CARE Center Northern NJ Medication-Assisted Treatment Center of Excellence (COE)
Evaluation of the Clinical Efficacy of an Application to Support Prescribing of Medication for Addiction Treatment Andrea M Jodat, CARN-AP, DNP, FNP-BC; Boston Medical Center
Exploring Cannabis Use Among Individuals Treated with Medication for Opioid Use Disorder: Correlates, Patterns, and Motivations for Use Sarah Leyde, MD1, Joseph O Merrill, MD, MPH2; (1)University of Washington, Harborview Medical Center, (2)University of Washington
Exploring Drug Checking Services for People Who Use Drugs and Harm Reduction Staff: Post-Implementation Study Whitney A Ludwig, MPH; University of Michigan
Feasibility and Learner Experience in a Multidisciplinary Addiction Training Program Joshua D Lee, MD1, Talia Rosen, BA1; (1)New York University Grossman School of Medicine
Female Veterans: 20-Year Trends of Access and Episodes of Buprenorphine for Opioid Use Disorder within the Veterans Health Administration Sophia Huebler, MSc; University of Utah
From Clinic to Consult Service: Navigating a Case of Ketamine Withdrawal Jose Alejandro Castellanos, MD1, Cory Johnson, MD, MPH1, Johanna Sluser, FNP-C, MSN1; (1)University of California, San Francisco
From Conception to Dissemination: Utilizing a Black-Led Community Advisory Board to Advance Racial Equity in Substance Use Research Kaytryn D Campbell, MA, MSc; University of Missouri, St. Louis
Harm Reduction Based Contingency Management for Stimulant Use Disorder Surabhi Nirkhe, MD1; Meredith Adamo, MD2; (1)New York City Health + Hospitals/Bellevue, (2)San Francisco Department of Public Health
Harm Reduction in a Cocaine Research Study: A Case Report Zachary Davis, Medical Student1, Lily Margaret Caglianone, BS1, Veronica M Bucci, BS1; (1)University of Illinois Chicago
Harm Reduction in Peer-Assisted Telemedicine for Hepatitis C: Secondary Outcomes of a Randomized Controlled Trial Hunter C. Spencer, DO, AAHIVS; Oregon Health & Science University
Harm Reduction Supply Distribution Via Vending Machines: 8-Month Outcomes for a California Veterans Affairs Health Care System Tessa Lynne Rife-Pennington, PharmD, BCGP; San Francisco Veterans Affairs Health Care System, University of California, San Francisco
Healing the ’Non-Healing’: A Holistic Approach to Treating Xylazine-Associated Wounds Tehya Johnson, AGPCNP-BC1, Christina Bailey, CARN, MSN, RN1; (1)Boston Health Care for the Homeless Program
Hearing Hope: The Power of Narrative Storytelling in Addiction Medicine Brittany L Carney, DNP, FNP-BC; Boston University Chobanian & Avedisian School of Medicine, Boston Medical Center
High-Dose Fentanyl and Buprenorphine Continuation As Support for the Treatment of Buprenorphine Precipitated Withdrawal Erik S Anderson, MD1, Megan Heeney, MD1, Kay R Lind, MD1; (1)Highland Hospital – Alameda Health System
Hospital-Based Navigation: A Tool for Linking Patients to Residential Addiction Treatment Sophie Zhai, BA; University of California, San Francisco
Implementation of a Substance Use Curriculum in an Academic Medical Center: Strategies to Expand Treatment of Substance Use Disorder Gilly Gehri, BA; University of Pennsylvania
Implementation of Post-Overdose Outreach Program Strategies and Toolkit Modules for Overdose Survivors Who Use Cocaine and Methamphetamine Sarah M. Bagley, MD; Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine
Implementation of Universal Screening for Posttraumatic Stress Disorder (PTSD) in an Opioid Treatment Program Alicia Wiprovnick, PhD; University of Maryland School of Medicine
Improving Alcohol Use Disorder Diagnosis and Treatment in a Primary Care Setting Using a Clinical Decision Support System Kevin Michael Pearlman, MD1, Mim Ari, MD1; (1)University of Chicago
Improving the Hospital Care Environment for People Who Use Drugs Jillian Zavodnick, MD1, Katie Mechler, MD1; Natalina Contoreggi, MD; Helene Dailey, DNP, RN, CCRN, CCCTM; Rebecca Jaffe, MD; (1)Thomas Jefferson University
An Interprofessional Model for Treating Alcohol Use Disorder in a Public Hospital Triveni DeFries, MD, MPH; University of California, San Francisco
Evaluation of Outcomes of Extended-Release Buprenorphine Administered during Emergency Department and Inpatient Visits Megan Heeney, MD1, Erik S Anderson, MD1, Robert Benard, ACNP, PMHNP-BC1; (1)Highland Hospital – Alameda Health System
Reduced Emergency Department Use Among Insured Individuals Receiving Extended-Release Buprenorphine in a Health System Setting Sarah J Leitz, MD; Kaiser Permanente
Tianeptine Use Disorder Treated with Methadone Maintenance: A Case Report Morgan Avery, MPH, PA-C; University of Colorado School of Medicine
“Nothing about Us without Us, Is for Us”: Creating a Harm Reduction Veteran Engagement Board to Inform Program Development Beth Dinges, PharmD; VA Illiana Healthcare System
Patients Perceptions of Physical Therapists Addressing Hazardous Drinking: A Cross-Sectional Study John Magel, PT, PhD, DSc; University of Utah
“It Wasn’t to Get High; It Was Just to Get By”: A Study of the Experience of Patients Who Use Illicitly Manufactured Fentanyl during Methadone Treatment and Recommendations to Improve Care Delivery in Vermont and New Hampshire; Jesse S Boggis, MPH ; Geisel School of Medicine at Dartmouth College
Increases in PrEP Awareness but Not PrEP Use Among People Who Inject Drugs Hunter C. Spencer, DO, AAHIVS; Oregon Health & Science University
It’s Complicated: A Peer-Taught Cannabis Prevention Education Program Emma R Wilson, BA; PreventEd
Long-Acting Injectable Antiretroviral Treatment Retention Among People with HIV Who Use Drugs Nicky J Mehtani, MD, MPH; University of California, San Francisco
Low-Dose Buprenorphine Initiation with and without 3 Days of Dispensed Methadone Among Patients at a Low-Threshold Addiction Clinic Lysa Samuel, PA1, Erik S Anderson, MD1; (1)Highland Hospital – Alameda Health System
Lower the Barriers: Treatment of Hepatitis C in an Opiate Treatment Program Laura Pugh, MD; University of California, San Francisco
Mechanisms of Overdose from Unintentional Fentanyl Use Among People Who Use Stimulants: A Qualitative Study Bryson O Gomez, Medical Student; University of California, San Francisco
Medications for Opioid Use Disorder (MOUD) in Massachusetts’ County Houses of Correction: Preliminary Findings on Post-Release Moud Treatment, Overdose, Reincarceration and Mortality Peter D Friedmann, MD, MPH; Baystate Health
Mobile Clinic for Individuals with Opioid Use Disorder: A Qualitative Analysis Cynthia A Tschampl, PhD; Brandeis University
Multi-Disciplinary Process for Patient-Centered Decisions on Take Home Medication in the Setting of Positive Toxicology in a Large, Urban Opioid Treatment Program Ari Kriegsman, MD1, Carissa Cutler, LICSW1, Hazel Barrett, LPN1; (1)Behavioral Health Network
Multi-Site Harm Reduction Kit Implementation and Distribution Margaret Shang, MD1, Raagini Jawa, MD2; (1)University of Pittsburgh Medical Center, (2)University of Pittsburgh
Non-Abstinence Among US Adults in Recovery: Findings from the 2022 National Survey on Drug Use and Health Emily Pasman, LMSW, PhD; University of Michigan
Nonprescription Syringe and over-the-Counter Naloxone Availability in Community Pharmacies: A Secret Shopper Purchase Audit in Austin, TX Shannon R Mayberry, BS, PharmD Candidate1, Jennifer E Lines, PharmD Candidate1; (1)The University of Texas at Austin College of Pharmacy
One Year in: The Impact of Addiction Consult Services in Improving Care for Hospitalized Patients with Substance Use Disorders M Holliday Davis, Clinical Research Coordinator; Center for Addiction Medicine and Policy, University of Pennsylvania
Operationalization of Long-Acting Pre-Exposure Prophylaxis for Socially Vulnerable Populations Sydney Yoon, BA; San Francisco Department of Public Health
Opioid Agonist Treatment Initiation Practices By Hospital-Based Addiction Consult Services Elana R Straus, BA, Medical Student; Yale University School of Medicine
Opioid-Induced Amenorrhea – Exploring the Impact of Chronic Opioid Use on Reproductive Health Safina Adatia, MD, MSc; Boston Medical Center
Outpatient Induction Using a 7-Day Extended-Release Injectable Buprenorphine for Patients with Opioid Use Disorder: Clinical Cases Elizabeth Ferro, MD; University of Pennsylvania
Pain Control and Self-Directed Discharge Among Hospitalized People with Opioid Use Disorder Michele J Buonora, MD, MHS, MSc; Montefiore Medical Center/Albert Einstein College of Medicine
Pairing Xylazine Education and Home Testing As a Harm Reduction Strategy for Pregnant and Postpartum Persons Who Use Illicit Opioids Ilana Hull, FASAM, MD, MSc1, Ellen Stewart, BS2; (1)University of Pittsburgh, (2)Magee Womens Research Institute
Patient and Navigator Experiences with the Opioid Use Disorder Treatment System in Philadelphia, Pennsylvania Megan K Reed, MPH, PhD; Thomas Jefferson University
Patient Characteristics Associated with Receipt of Contingency Management for Stimulant Use Disorder in the Veterans Health Administration Madeline C Frost, MPH, PhD; Veterans Affairs Puget Sound Healthcare System
Peer Led Substance Use Disorder Navigation to Support Reentry for Returning Citizens Nicole O’Donnell, BA; University of Pennsylvania
Peer Recovery Coach (PRC) As an Intervention for Incarcerated Individuals with Opioid Use Disorder (OUD): Perceptions from Staff Elizabeth Haberkorn, DNP, FNP-BC; University of Michigan
Perspectives of Mothers with Substance Use Disorder on Naloxone Education: “I’m Ready to Have Those Conversations about Who I Was, Because That’s Not Who I Am” Jessica B Calihan, MD, MSc; Boston Children’s Hospital
Pilot Evaluation of a Novel, Cooperative Opioid Use Disorder (OUD) Board Game Molly A. Nichols, MSc, PharmD; Purdue University College of Pharmacy
Polysubstance-Involved Opioid Overdose Deaths Among US Youth, 2020 to 2023 Connor Buchholz, MSc1, Scott E Hadland, MD, MPH, MSc2, Meredith Glass, MPH2; (1)Boston University School of Public Health, (2)Massachusetts General Hospital
Preparing Colorado Health Professionals in Primary Care and School-Based Health Centers (SBHCs) to Intervene Early for Adolescent Substance Use through Screening, Brief Intervention, and Referral to Treatment (SBIRT) Nora M Marino, MPH; NORC at the University of Chicago
Preparing Healthcare Workers to Discuss Harm Reduction with Patients Who Use Drugs through a Brief Workshop Patricia Moreno, BS; University of California, San Francisco
Provider Experiences of Substance Use-Related Disorder Management in Pediatric Hospitals: A Qualitative Analysis of Key Informant Interviews Adam Kronish, MD; Children’s Hospital of Philadelphia
Providers’ Knowledge and Perception of Xylazine in the Unregulated Drug Supply: A Sequential Explanatory Mixed-Methods Study Katherine Hill, BA, MPH, PhD Candidate; Yale School of Public Health
Public Perceptions of Opioid Misuse Recovery and Related Resources in a Nationally Representative Sample of U.S. Adults Olivia Golan, PhD; NORC at the University of Chicago
Public Transit Access to Methadone Treatment in Miami-Dade County, Florida Marina Plesons, MPH; University of Miami Miller School of Medicine
Rapid Transition from a Continuous Naloxone Infusion to Sublingual Buprenorphine after an Opioid Overdose Anthony Spadaro, MD, MPH1, Emily A Gordon, MD1; (1)Rutgers New Jersey Medical School
Rebuilding Hope: A Contingency Framework for Stimulant Use Among Unhoused Anusha Chandrakanthan, FAAFP, MD; Valley Homeless Healthcare Program, Santa Clara Valley Medical Center
Reimagining Recovery: A Health Justice-Oriented Training for Professionals By Michigan State University Extension Lauren E Kennedy, PhD; Michigan State University Extension
Rethinking Harm Reduction Conversations: An Oronasal Fistula in a Woman Snorting Xylazine-Fentanyl Elizabeth Ferro, MD; Allegheny Health Network
Reversal of Opioid Overdose with Intravenous Buprenorphine and Rapid Transition to Extended-Release Buprenorphine Josh Luftig, PA-C1,2, Michelle Patregnani, MD1; (1)Highland Hospital – Alameda Health System, (2)CA Bridge
Risk Factors for Chronic Pain Among People Who Inject Drugs in Denver, CO and Los Angeles, CA, 2021/22 Jimi Huh, PhD; University of Southern California
Risk Perceptions, Parental Substance Use, and Peer Disapproval Predict Early Onset Substance in Adolescents with Comorbid Psychologic and Somatic Symptom Trajectories Sarah A Stoddard, FAAN, PhD, RN; University of Michigan
Rural Community Pharmacist Knowledge of Drug Checking Test Strips and Willingness to Engage with Test Strip Activities Grace T Marley, PharmD; University of North Carolina Eshelman School of Pharmacy, South East Area Health Education Center, University of North Carolina Wilmington
Rural Pregnant Women with Substance Use Disorder: A Grounded Theory Study Cami Weber, MBA, PhD, RN; Webster University
Scaling a Virtual Buprenorphine Bridge Clinic: Outcomes and Lessons Learned Patrick Joseph Dooley1, James S. Sherman, CPS1; (1)University of Pennsylvania
Search and Seizure: A Descriptive Analysis of Hospital Searches Among Patients with Substance Use Disorders Sarah Nessen, BA, Medical Student; Perelman School of Medicine, University of Pennsylvania, Penn Center for Emergency Care and Policy Research, Penn Center for Addiction Medicine and Policy
Self-Reported Readiness to Change Alcohol Use in Emergency Department Patients with Alcohol Use Disorder Predicts Successful Linkage to Treatment Caitlin R Ryus, MD, MPH; Yale University School of Medicine
Silent Struggles: Unveiling Stigma in Healthcare with Perinatal Opioid Use Disorder Rebecca Schapiro, MD1, Nia M Bhadra-Heintz, MD, MSc1; (1)Hospital of the University of Pennsylvania
Stigma-Free Access to Harm Reduction Supplies: A Cross-Sector Approach Shelby Arena, BA; MATTERS – UBMD Emergency Medicine
Student Led Harm Reduction Outreach: Educational and Community Impact Eli M Solomon, Medical Student; University of California, San Diego, Harm Reduction IHC
Suicidal Ideation Among Non-Psychiatric Patients with Opioid Use Disorder in an Urban Emergency Department: Correlates and Future Overdose Events Lauren K Whiteside, MD; University of Washington
Supporting Hospitalized Adults with Stimulant Use Disorder Using a Mobile App Contingency Management Program Linda Peng, MD; Oregon Health & Science University
Surmounting Stigma: Missouri First Responder Attitudes Towards People Who Use Drugs Improve Following Training Saad T Siddiqui, MPH; Missouri Institute of Mental Health
Systematically Testing the Evidence on Marijuana Devan Kansagara, MCR, MD; Oregon Health & Science University
Telemedicine Hotline to Improve Access to Medications for Opioid Use Disorder — Illinois and MAR NOW Nicole Gastala, MD1, Maria Bruni, PhD2; (1)Substance Use Prevention and Recovery Division, (2)Family Guidance Centers, Inc.
Test Your Drugs, Not Your Limits: Advanced Drug Checking As an Enhancement to Harm Reduction and Medical Services at a Community Health Center Allyson Pinkhover, MPH; Brockton Neighborhood Health Center, Johns Hopkins University Bloomberg School of Public Health
The Civil Right to Medication for Opioid Use Disorder Amelia Caramadre, JD, MPH1; Ruchi V Shah, DO2; (1)Kaplan & Grady, LLC, (2)Boston Medical Center
The Good, the Bad, and the Ugly: Patient Perspectives on Low Dose Buprenorphine Initiation in the Outpatient Setting in the Fentanyl Era Leslie W. Suen, MAS, MD; University of California, San Francisco
The Impact of Anti-Stigma Education in the Healthcare Field: A Program Design Madison Walsh, MSc1, Dr. Cara Anne Poland, MD, MEd1; (1)Michigan State University
The Impact of Near-Peer Teaching on a Naloxone Training Workshop and Opioid Overdose Simulation Jachua Polcyn, MD Candidate1, Nicole Rockich-Winston, PharmD1; (1)Medical College of Georgia at Augusta University
The OSU System-Wide Addiction Services Program – Bolstering a Tertiary Care Center’s Addiction Safety Net Martin Clendenning Fried, MD, FACP; Ohio State University
The Problem Posed By the Lack of Racial Diversity in Co-Occurring Substance Use and Posttraumatic Stress Disorder Research Mallet R. Reid, PhD Candidate; Michigan State University
The Role of Hospital Climate and Nurse Stigma on Implementation of Chestfeeding and Skin-to-Skin Care for Neonatal Opioid Withdrawal Syndrome Clayton J Shuman, PhD, MSN, RN; University of Michigan
Toward a Deeper Understanding of Suicides That Follow Prescription Opioid Reduction in Pain: Preliminary Results from 19 Psychological Autopsies Stefan G Kertesz, MD; Birmingham Alabama Veterans Health Care System
Towards a Consensus on Strategies to Support Opioid Use Disorder Care Transitions Following Hospitalization: A Modified Delphi Process Noa Krawczyk, PhD; New York University Grossman School of Medicine
Trends in Nonfatal Opioid Overdose Among Veterans Health Administration Patients with Opioid Use Disorder Following COVID-Related Policy Changes for Opioid Use Disorder Treatment Madeline C Frost, MPH, PhD; Veterans Affairs Puget Sound Healthcare System
Understanding Resiliency in People Who Use Methamphetamine Demographically Matched to Acute Stimulant Toxicity Decedents Nigel Anderson; San Francisco Department of Public Health
Unravelling the Opioid Crisis in Urban Centers: Community Strategies to Address Overdose Deaths in Boston, MA Evans F Kyei, BSN, MSN, PhD Candidate, RN; University of Massachusetts Boston
US and Canadian Medical Student Attitudes Toward People Who Inject Drugs: An Online Survey Tucker Avra1, Andrew Nelson, Medical Student2; (1)David Geffen School of Medicine at UCLA, (2)A.T. Still University School of Osteopathic Medicine
We Have the Right to Know: Building a Drug User-Owned Drug Checking Network in Texas Claire M Zagorski, MSc, LP; The University of Texas at Austin College of Pharmacy
What a Difference This Home Makes: Changes in Drug Use, HIV Risk and Prevention Behaviors Among Residents Relocated from Encampments to Low-Threshold Harm Reduction Housing Sites in Boston Traci C Green, MSc, PhD; Brandeis University
Would We, Could We? Measuring Attitudinal and Capacity Barriers to Supporting Residents on MOUD in Recovery Housing Rachel Winograd, PhD; University of Missouri, St. Louis
Xylazine-Associated Wounds Among Hospitalized Patients in Philadelphia Lydia Lutz, MD; Johns Hopkins University School of Medicine
Expanding Access to Addiction Knowledge: Engaging High School Students with Addiction Medicine Content Sophia Many Ly, Medical Student1, Amanda Marie Fitzpatrick, Medical Student, MPH1; (1)Boston Medical Center
Medications for Alcohol Use Disorder and Withdrawal: A National Sample of Patients Discharged from the Emergency Department Kathryn Hawk, MD, MHS; Yale University School of Medicine
Seeking Solutions: The Role of Behaviors and Personal and Social Beliefs in College Alcohol Help-Seeking Intent Benjamin N Montemayor, PhD; Texas A&M University School of Public Health
From Evidence to Action: A Retrospective Chart Review of Prescribing Factors Associated with Extended-Release Buprenorphine Retention in an Integrated Clinic Setting Sami Hamdan, MD, MPH1, Kenneth L. Morford, MD1; (1)Yale University School of Medicine
Leveraging Community Advisory Boards (CABs) to Enhance the Uptake of Harm Reduction Initiatives in West Philadelphia Jasmine S Barnes, MPH; University of Pennsylvania
Patterns of Opioid Misuse and Related Clinical Signs Among Veterans with Subsyndromal Opioid Use Disorder: A Latent Class Analysis Jayden Yu Henneman, BA; University of Michigan